AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2015
Nov 19, 2015
34576_dirs_2015-11-18_91e6012b-8d35-4168-9ed2-3b1299f66cbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-11-17
Reporting Person: Yu K Peony (VP, Clinical Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-17 | Common Stock | S | 5000 | $28.00 | Disposed | 183345 | Direct |
Footnotes
F1: Shares sold pursuant to a 10b5-1 plan.
F2: Includes 441 shares acquired on November 13, 2015 through the Issuer's Employee Stock Purchase Plan.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10